Literature DB >> 20952590

Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction.

Reshef Tal1, Aviv Shaish, Iris Barshack, Silvia Polak-Charcon, Arnon Afek, Alexander Volkov, Boris Feldman, Camila Avivi, Dror Harats.   

Abstract

Preeclampsia and intrauterine growth restriction (IUGR) are pregnancy-specific disorders that share a common pathophysiology. Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that plays an important role in placental development. HIF-1α is elevated in preeclamptic placentas and induces soluble vascular endothelial growth factor receptor-1 (sFLT-1), a central factor in preeclampsia and IUGR pathogenesis. Our objective was to investigate the effects of HIF-1α overexpression on pregnancy in mice. C57BL/6J pregnant mice were systemically administered either adenovirus expressing stabilized HIF-1α (cytomegalovirus [CMV]-HIF), luciferase control (CMV-Luc), or saline on gestational day 8. Pregnant mice overexpressing HIF-1α had significantly elevated blood pressure and proteinuria compared with pregnant controls. HIF-1α mice showed fetal IUGR, decreased placental weights, and histopathological placental abnormalities compared with control mice. Glomerular endotheliosis, the hallmark lesion of preeclampsia, was demonstrated in the kidneys of these mice relative to the normal histology in control mice. Moreover, liver enzyme levels were significantly elevated, whereas complete blood counts revealed significant anemia and thrombocytopenia in CMV-HIF mice compared with controls. Blood smears confirmed microangiopathic hemolytic anemia in CMV-HIF mice, consistent with HELLP (hemolysis, elevated liver enzymes, and low platelets)-like syndrome. CMV-HIF mice showed elevation in serum sFLT-1 and soluble endoglin, providing a mechanistic explanation for the observations. Collectively, our results suggest a possible role for HIF-1α in the pathogenesis of both preeclampsia and IUGR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952590      PMCID: PMC2993274          DOI: 10.2353/ajpath.2010.090800

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

2.  Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. 1982.

Authors:  Louis Weinstein
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 3.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

Review 4.  Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.

Authors:  Roberta B Ness; Baha M Sibai
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

5.  Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

Authors:  Ori Nevo; Nima Soleymanlou; Yuan Wu; Jing Xu; John Kingdom; Ariel Many; Stacy Zamudio; Isabella Caniggia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

6.  Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand.

Authors:  J Hu; D J Discher; N H Bishopric; K A Webster
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

7.  In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine model for studying placental angiogenesis.

Authors:  E Geva; D G Ginzinger; D H Moore; P C Ursell; R B Jaffe
Journal:  Mol Hum Reprod       Date:  2005-02-25       Impact factor: 4.025

8.  Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.

Authors:  Wenzel Wallner; Ruth Sengenberger; Reiner Strick; Pamela L Strissel; Britta Meurer; Matthias W Beckmann; Dietmar Schlembach
Journal:  Clin Sci (Lond)       Date:  2007-01       Impact factor: 6.124

9.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

10.  Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions.

Authors:  Soo Bong Lee; Amy P Wong; Keizo Kanasaki; Yong Xu; Vivek K Shenoy; Thomas F McElrath; George M Whitesides; Raghu Kalluri
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

View more
  43 in total

1.  Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring.

Authors:  Eliel Kedar Sade; Tamar Wainstock; Erez Tsumi; Eyal Sheiner
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

2.  Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen.

Authors:  Yi-Zhou Jiang; Yan Li; Kai Wang; Cai-Feng Dai; Shi-An Huang; Dong-Bao Chen; Jing Zheng
Journal:  Mol Cell Endocrinol       Date:  2014-05-02       Impact factor: 4.102

Review 3.  Current model systems for the study of preeclampsia.

Authors:  M L Martinez-Fierro; G P Hernández-Delgadillo; V Flores-Morales; E Cardenas-Vargas; M Mercado-Reyes; I P Rodriguez-Sanchez; I Delgado-Enciso; C E Galván-Tejada; J I Galván-Tejada; J M Celaya-Padilla; I Garza-Veloz
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-07

Review 4.  Trophoblast lineage specification, differentiation and their regulation by oxygen tension.

Authors:  Ching-Wen Chang; Anna K Wakeland; Mana M Parast
Journal:  J Endocrinol       Date:  2018-01       Impact factor: 4.286

5.  Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

Authors:  Dorien Reijnders; Chin-Chi Liu; Xinjing Xu; Anna M Zhao; Kelsey N Olson; Scott D Butler; Nataki C Douglas; Jenny L Sones
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

6.  VEGF-A regulates sFlt-1 production in trophoblasts through both Flt-1 and KDR receptors.

Authors:  Zhonglin Xiao; Songjun Li; Yan Yu; Mengxia Li; Jie Chen; Feng Wang; Jian Zhang; Weifen Deng; Qing Yang; Xiujun Fan
Journal:  Mol Cell Biochem       Date:  2018-03-01       Impact factor: 3.396

7.  Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency.

Authors:  Carmen J Williams; Alison Chu; Wendy N Jefferson; David Casero; Deepthi Sudhakar; Nevil Khurana; Claire P Hogue; Chinmayi Aryasomayajula; Priya Patel; Peggy Sullivan; Elizabeth Padilla-Banks; Shabnam Mohandessi; Carla Janzen; Madhuri Wadehra
Journal:  J Pathol       Date:  2017-05-03       Impact factor: 7.996

Review 8.  Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes.

Authors:  Sachin A Gupte; Michael S Wolin
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

9.  Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression.

Authors:  Kirsten Palmer; Burcu Saglam; Clare Whitehead; Owen Stock; Martha Lappas; Stephen Tong
Journal:  Am J Pathol       Date:  2011-04-30       Impact factor: 4.307

Review 10.  Pre-eclampsia part 1: current understanding of its pathophysiology.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.